GEN Exclusives

More »

GEN News Highlights

Back to Item »

Prolor Biotech to Use The University of Queensland’s Human Growth Hormone Cell Line

Deal allows firm to determine potency of its long-acting version of HGH and identify relevant neutralizing antibodies.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »